NANOCAFLANONE

Serial Number 99214024
688

Registration Progress

Application Filed
Jun 2, 2025
Under Examination
Jan 20, 2026
Approved for Publication
Nov 25, 2025
Published for Opposition
Nov 25, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jul 20, 2026 170 days

Trademark Image

NANOCAFLANONE

Basic Information

Serial Number
99214024
Filing Date
June 2, 2025
Published for Opposition
November 25, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Jan 20, 2026
Application
Pending
Classes
005

Rights Holder

Flavocure Biotech Inc.

03
Address
701 E. Pratt Street
Suite 2033
Baltimore, MD 21202

Ownership History

Flavocure Biotech Inc.

Original Applicant
03
Baltimore, MD

Flavocure Biotech Inc.

Owner at Publication
03
Baltimore, MD

Legal Representation

Attorney
Benjamen E. Kern

USPTO Deadlines

Next Deadline
170 days remaining
NOA E-Mailed - SOU Required
Due Date
July 20, 2026
Extension Available
Until January 20, 2027

Application History

13 events
Date Code Type Description Documents
Jan 20, 2026 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 25, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 25, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 19, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 27, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 24, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 24, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 24, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Oct 24, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 21, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 2, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jun 2, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 2, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Diagnostic agents, preparations and substances for medical purposes; diagnostic agents for medical use, namely, diagnostic agents for in vivo use; pharmaceutical diagnostic preparations for medical use; pharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases; Pharmaceutical compositions for detection, diagnosis, and treatment of central nervous system disorders, cancers, and inflammatory diseases

Classification

International Classes
005